UTHR — United Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for United Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,931	2,839	2,994	3,267	2,920
Net Total Accounts Receivable
Net Total Receivables	199	220	279	279	350
Total Inventory
Total Other Current Assets
Total Current Assets	2,324	3,380	3,551	3,874	3,703
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	781	862	1,045	1,222	1,730
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5,169	6,045	7,167	7,364	7,880
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	305	343	804	738	561
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	1,210	1,248	1,182	920	784
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	3,959	4,797	5,985	6,444	7,096
Total Liabilities & Shareholders' Equity	5,169	6,045	7,167	7,364	7,880
Total Common Shares Outstanding